Combination Therapy with SGLT2 Inhibitors and GLP-1 Receptor Agonists for Diabetic Kidney Disease

J Am Soc Nephrol. 2025 Jan 7. doi: 10.1681/ASN.0000000620. Online ahead of print.

Authors

Mengyao Tang^{1

2}, Mario Luca Morieri³, Sahir Kalim^{1

2}, Alessandro Doria^{2

4}

Affiliations

¹ Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Boston, MA.
² Department of Medicine, Harvard Medical School, Boston, MA.
³ Department of Medicine, University of Padua, Italy.
⁴ Research Division, Joslin Diabetes Center, Boston, MA.

PMID: 39774583
DOI: 10.1681/ASN.0000000620

No abstract available

Grants and funding

R01 DK124453/DK/NIDDK NIH HHS/United States